Betaxolol Hydrochloride NDC 61314-245

NDC codes

FDA NDC Directory

Product NDC (as listed)61314-245Labeler and product segments. Claims need a package NDC.

Product NDC at billing width61314-0245Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
61314-245-01	61314024501	1 BOTTLE, PLASTIC in 1 CARTON (61314-245-01) / 5 mL in 1 BOTTLE, PLASTICMarketed from May 15, 2000
61314-245-02	61314024502	1 BOTTLE, PLASTIC in 1 CARTON (61314-245-02) / 15 mL in 1 BOTTLE, PLASTICMarketed from May 15, 2000
61314-245-03	61314024503	1 BOTTLE, PLASTIC in 1 CARTON (61314-245-03) / 10 mL in 1 BOTTLE, PLASTICMarketed from May 15, 2000

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Betaxolol Hydrochloride
Generic name (nonproprietary): betaxolol hydrochloride
Active ingredients: Betaxolol hydrochloride — 5.6 mg/mL
Dosage form: Solution/ drops
Route: Ophthalmic
Labeler: Sandoz Inc
Product type: Prescription drug
Marketing category: NDA authorized genericApplication NDA 019270
Marketing start: May 15, 2000
Listing expires: Dec 31, 2026
Other FDA classes: Adrenergic beta-Antagonists (Mechanism)
Identifiers: Product ID 61314-245_c30e555b-1a79-4c3e-b79d-8c1d950fd832SPL ID c30e555b-1a79-4c3e-b79d-8c1d950fd832SPL set ID a73519d5-546c-4377-92ed-0d4be2685d60RxCUI 308720UNII 6X97D2XT0O
Pharmacologic class: beta-Adrenergic Blocker

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Ophthalmic products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N461314024501 followed by a unit qualifier and the quantity

Package 61314-0245-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Oct 31, 2023.

Indications (excerpt from the label)

INDICATIONS AND USAGE Betaxolol Hydrochloride Ophthalmic Solution has been shown to be effective in lowering intraocular pressure and is indicated in the treatment of ocular hypertension and chronic open-angle glaucoma. It may be used alone or in combination with other anti-glaucoma drugs. In clinical studies, Betaxolol Hydrochloride Ophthalmic Solution was safely used to lower intraocular pressure in 47 patients with both glaucoma and reactive airway disease who were followed for a mean period of 15 months. However, caution should be used in treating patients with severe reactive airway disease or a history of asthma.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)